Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,028,900 | 627,300 | 285,143 | 117,005 | 68,826 |
| Cost of Goods | 408,100 | 234,600 | 144,214 | 65,363 | N/A |
| Gross Profit | 620,800 | 392,700 | 140,929 | 51,642 | 68,826 |
| Operating Expenses | 922,200 | 591,000 | 553,717 | 507,833 | 468,922 |
| Operating Income | -301,300 | -197,700 | -412,574 | -455,828 | -400,096 |
| Other Income | 18,700 | 39,600 | -107,544 | 10,104 | -7,100 |
| Pre-tax Income | -282,600 | -158,100 | -520,118 | -445,724 | -407,196 |
| Income Tax | 14,200 | 18,900 | -1,864 | 625 | -3,614 |
| Net Income Continuous | -296,800 | -177,000 | -518,254 | -446,349 | -403,582 |
| Net Income | $-296,800 | $-177,000 | $-518,254 | $-446,349 | $-403,582 |
| EPS Basic Total Ops | -1.62 | -0.96 | -2.94 | -2.80 | -2.86 |
| EPS Basic Continuous Ops | -1.61 | -0.97 | -2.94 | -2.81 | -2.87 |
| EPS Diluted Total Ops | -1.62 | -0.96 | -2.94 | -2.80 | -2.86 |
| EPS Diluted Continuous Ops | -1.61 | -0.97 | -2.94 | -2.81 | -2.87 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.52 | -1.23 | -1.30 | -1.35 |
| EBITDA(a) | $-272,400 | $-176,300 | $-392,123 | $-437,436 | $-386,179 |